An anticancer drug opens a new path for the treatment of Parkinson’s

by Institute for Advanced Chemistry of Catalonia (IQAC-CSIC)

The fact that M324 is capable of reducing the abnormal accumulation of α-synuclein in neurons derived from stem cells of a Parkinson’s patient, highlights the therapeutic potential of this metaboli...

Read more

The accumulation of a protein associated with Parkinson disease in the serotonin neurons triggers depression and anxiety

by Fundació Clínic per a la Recerca Biomèdica

Researchers at IDIBAPS and the CSIC’s Barcelona Biomedical Research Institute (IIBB) have developed a new preclinical model to study the non-motor symptoms of Parkinson disease. The model is based o...

Read more
Subscribe to Directory
Write an Article

Recent News

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Un ensayo de microscopía dinámica del ...

by CSIC - Centro Superior de Investigaciones Científicas

La revista ‘Nature Protocols’ selecciona esta técnica como “pro...

Photos Stream